Beam Therapeutics Inc (BEAM)

Dec 09, 2025

Evercore ISI Remains a Buy on Beam Therapeutics (BEAM) - The Globe and Mail

Dec 09, 2025

Dec 08, 2025

JonesTrading Maintains Beam Therapeutics(BEAM.US) With Buy Rating, Maintains Target Price $35 - 富途牛牛

Dec 08, 2025

Dec 08, 2025

ASH: Beam Can Rival Vertex In Sickle Cell But Bulsufan Deaths Cast A Shadow - Citeline News & Insights

Dec 08, 2025

Dec 08, 2025

Beam Therapeutics edges higher after new sickle cell therapy results - MSN

Dec 08, 2025

Dec 08, 2025

Beam Therapeutics stock rises on promising sickle cell therapy data By Investing.com - Investing.com UK

Dec 08, 2025

Dec 08, 2025

Beam Therapeutics stock rises on promising sickle cell therapy data - Investing.com

Dec 08, 2025

Dec 07, 2025

(BEAM) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Dec 07, 2025

Dec 07, 2025

Beam Therapeutics (BEAM) Reveals Positive Trial Results at Hemat - GuruFocus

Dec 07, 2025

Dec 07, 2025

Beam Therapeutics (BEAM): Reassessing Valuation After New BEACON Sickle Cell Trial Results and Renewed Momentum - Yahoo Finance

Dec 07, 2025

Dec 06, 2025

Beam Therapeutics (BEAM) Is Up 6.9% After New BEACON Trial Data Spotlight Base-Editing Potential - Yahoo Finance

Dec 06, 2025

Dec 06, 2025

Beam reports positive data from sickle cell disease gene therapy trial By Investing.com - Investing.com South Africa

Dec 06, 2025

Dec 06, 2025

Beam reports positive data from sickle cell disease gene therapy trial - Investing.com

Dec 06, 2025

Dec 06, 2025

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting - The Manila Times

Dec 06, 2025

Dec 06, 2025

Beam Therapeutics Reports Promising Updates on Risto-cel for Sickle Cell Disease at 67th ASH Annual Meeting - Quiver Quantitative

Dec 06, 2025

Dec 06, 2025

38,438 Shares in Beam Therapeutics Inc. $BEAM Purchased by Capital Fund Management S.A. - MarketBeat

Dec 06, 2025

Dec 05, 2025

Beam Therapeutics stock surges 64% since InvestingPro’s April undervalued call By Investing.com - Investing.com Australia

Dec 05, 2025

Dec 05, 2025

BEAM (Beam Therapeutics) Capex-to-Operating-Income : 0.00 (As of Sep. 2025) - GuruFocus

Dec 05, 2025

Dec 05, 2025

How Beam Therapeutics Inc. stock compares to industry benchmarksProfit Target & AI Powered Market Entry Strategies - Newser

Dec 05, 2025

Dec 04, 2025

Beam Therapeutics (BEAM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 04, 2025

Dec 04, 2025

Beam Therapeutics: Strong Buy On BEAM-101 Progress And In Vivo LNP Shots On Goal - Seeking Alpha

Dec 04, 2025

Dec 04, 2025

Beam Therapeutics (NASDAQ:BEAM) Stock Price Up 6.8%What's Next? - MarketBeat

Dec 04, 2025

Dec 04, 2025

Why Is Beam Therapeutics (BEAM) Up 15.9% Since Last Earnings Report? - Yahoo Finance

Dec 04, 2025

Dec 04, 2025

Published on: 2025-12-04 06:37:06 - Newser

Dec 04, 2025

Dec 04, 2025

Why analysts remain bullish on Beam Therapeutics Inc. stockJuly 2025 Trends & Community Verified Trade Signals - Newser

Dec 04, 2025

Dec 04, 2025

Beam Therapeutics Earnings Notes - Trefis

Dec 04, 2025

Dec 03, 2025

Beam Therapeutics (BEAM) Experiences Significant Stock Surge - GuruFocus

Dec 03, 2025

Dec 03, 2025

Will Beam Therapeutics Inc. stock split again soonSell Signal & Daily Volume Surge Trade Alerts - Newser

Dec 03, 2025

Dec 03, 2025

Will Beam Therapeutics Inc. stock pay special dividends2025 Stock Rankings & Precise Swing Trade Entry Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Is Beam Therapeutics Inc. stock attractive for ETFsRate Cut & Safe Entry Point Identification - Newser

Dec 02, 2025

Nov 28, 2025

Beam Therapeutics Advances BEAM-302 Study for AATD: Key Insights for Investors - MSN

Nov 28, 2025

Nov 28, 2025

Geode Capital Management LLC Grows Position in Beam Therapeutics Inc. $BEAM - MarketBeat

Nov 28, 2025

Nov 28, 2025

14,601 Shares in Beam Therapeutics Inc. $BEAM Bought by Entropy Technologies LP - MarketBeat

Nov 28, 2025

Nov 28, 2025

BEAM vs. NTLA: Which Gene Editing Stock Holds More Potential? - sharewise.com

Nov 28, 2025

Nov 27, 2025

Beam Therapeutics (BEAM) Earnings Transcript - Nasdaq

Nov 27, 2025

Nov 27, 2025

How resilient is Beam Therapeutics Inc. stock in market downturnsOil Prices & Stepwise Swing Trade Plans - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

Beam Therapeutics (NASDAQ:BEAM) Earns Outperform Rating from Analysts at Evercore ISI - MarketBeat

Nov 27, 2025

Nov 26, 2025

Is Beam Therapeutics Inc. stock a defensive play in 20252025 Winners & Losers & Free Technical Pattern Based Buy Signals - BỘ NỘI VỤ

Nov 26, 2025

Nov 26, 2025

(BEAM) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Nov 26, 2025

Nov 25, 2025

ETFs Investing in Beam Therapeutics Inc. Stocks - TradingView

Nov 25, 2025

Nov 25, 2025

Evercore ISI Group Initiates Coverage of Beam Therapeutics (BEAM) with Outperform Recommendation - MSN

Nov 25, 2025

Nov 24, 2025

Beam Therapeutics (BEAM) Receives New 'Outperform' Rating from E - GuruFocus

Nov 24, 2025

Nov 23, 2025

Beam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease Trial - MSN

Nov 23, 2025

Nov 21, 2025

How Beam Therapeutics Inc. stock valuations compare to rivals - newser.com

Nov 21, 2025

Nov 20, 2025

Analyzing drawdowns of Beam Therapeutics Inc. with statistical toolsAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com

Nov 20, 2025

Nov 20, 2025

Is Beam Therapeutics Inc. stock supported by innovation pipeline2025 Key Lessons & Capital Efficiency Focused Strategies - newser.com

Nov 20, 2025

Nov 19, 2025

How Beam Therapeutics Inc. stock compares to market leaders2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Beam Therapeutics (BEAM) Strengthens Cash Position as Key Trials Move Forward - MSN

Nov 19, 2025

Nov 19, 2025

Historical volatility pattern of Beam Therapeutics Inc. visualized2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Why retail investors favor Beam Therapeutics Inc. stockJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 19, 2025